• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载羽扇豆醇的纳米粒子通过抑制 Raf/丝裂原活化蛋白激酶和磷酸肌醇 3 激酶/哺乳动物雷帕霉素靶蛋白通路的过度激活增强肝癌的放射敏感性。

Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways.

机构信息

Clinical Laboratory Medicine, First Affiliated Hospital, Anhui University of Science & Technology, Huainan, 232001, China.

出版信息

J Biomed Nanotechnol. 2021 Nov 1;17(11):2247-2258. doi: 10.1166/jbn.2021.3194.

DOI:10.1166/jbn.2021.3194
PMID:34906285
Abstract

Radioresistance limits the effectiveness of radiotherapy for hepatocellular carcinoma. Raf and PI3K signaling cascades promote the formation of radioresistance in hepatocellular carcinoma (HCC). Lupeol has anticancer activity despite itspoor solubility in water and is toxic effect on normal tissue. In this study, nanoparticles (lupeol-NPs) were constructed using PEG-PLGA diblock copolymer vector, and results revealed that Lupeol-NPs reversed the radioresistance of hepatocellular carcinoma by inhibiting cellular proliferation and cell-cycle progression and promoting cellular apoptosis through blocking Raf/MAPK and PI3K/Akt signal transduction in radioresistant Huh-7 cells. , Lupeol-NPs combined with radiotherapy inhibited the growth of radioresistant hepatocellular carcinoma in a xenogenic nude mouse model. Ki-67 proliferation index decreased significantly ( < 0.05). We conclude that Lupeol-NPs can increase the sensitivity of radioresistant hepatocellular carcinoma to radiotherapy through inhibiting the Raf and PI3K signal cascades.

摘要

放射抗拒限制了肝癌的放射治疗效果。Raf 和 PI3K 信号级联促进肝癌(HCC)形成放射抗拒。尽管羽扇醇在水中的溶解度差且对正常组织有毒性作用,但它仍具有抗癌活性。在这项研究中,使用 PEG-PLGA 两亲嵌段共聚物载体构建了纳米颗粒(羽扇醇-NPs),结果表明,羽扇醇-NPs 通过阻断 Raf/MAPK 和 PI3K/Akt 信号转导,在耐辐射 Huh-7 细胞中抑制细胞增殖和细胞周期进程,促进细胞凋亡,从而逆转肝癌的放射抗拒。羽扇醇-NPs 联合放射治疗抑制了异种裸鼠模型中耐辐射肝癌的生长。Ki-67 增殖指数显著降低(<0.05)。我们得出结论,羽扇醇-NPs 通过抑制 Raf 和 PI3K 信号级联,可增加耐辐射肝癌对放射治疗的敏感性。

相似文献

1
Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways.负载羽扇豆醇的纳米粒子通过抑制 Raf/丝裂原活化蛋白激酶和磷酸肌醇 3 激酶/哺乳动物雷帕霉素靶蛋白通路的过度激活增强肝癌的放射敏感性。
J Biomed Nanotechnol. 2021 Nov 1;17(11):2247-2258. doi: 10.1166/jbn.2021.3194.
2
PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.PI-103 和索拉非尼通过阻断 Ras/Raf/MAPK 和 PI3K/AKT/mTOR 通路抑制肝癌细胞增殖。
Anticancer Res. 2010 Dec;30(12):4951-8.
3
Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.去γ-羧基凝血酶原通过激活Raf/MEK/ERK和PI3K/Akt/mTOR信号通路拮抗索拉非尼对人肝细胞癌的作用。
Oncotarget. 2016 Jun 14;7(24):36767-36782. doi: 10.18632/oncotarget.9168.
4
Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.PDK1 表达升高驱动 PI3K/AKT/MTOR 信号促进肝癌的辐射抵抗和去分化表型。
Cells. 2020 Mar 18;9(3):746. doi: 10.3390/cells9030746.
5
Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.新型双重 PI3K/mTOR 抑制剂 CMG002 单独及联合索拉非尼在肝癌中的临床前疗效。
Cancer Chemother Pharmacol. 2019 Oct;84(4):809-817. doi: 10.1007/s00280-019-03918-y. Epub 2019 Aug 5.
6
A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.羽扇豆醇通过抑制脑源性神经营养因子和再激活糖原合成酶激酶 3β诱导肝癌细胞凋亡的新机制。
Eur J Pharmacol. 2015 Sep 5;762:55-62. doi: 10.1016/j.ejphar.2015.05.030. Epub 2015 May 21.
7
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.靶向PI3K/AKT/mTOR和Ras/Raf/MAPK通路的PKI-587与索拉非尼协同抑制肝癌细胞增殖。
J Surg Res. 2012 Aug;176(2):542-8. doi: 10.1016/j.jss.2011.10.045. Epub 2011 Nov 21.
8
The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment.PI3K/mTOR 抑制与索拉非尼联合治疗肝细胞癌的作用。
Anticancer Res. 2012 Jul;32(7):2531-6.
9
Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.“同类首创”双PI3K/BRD4抑制剂SF1126与索拉非尼在肝细胞癌中的单药活性及协同活性
Mol Cancer Ther. 2016 Nov;15(11):2553-2562. doi: 10.1158/1535-7163.MCT-15-0976. Epub 2016 Aug 5.
10
Lupeol enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo.羽扇豆醇在体外和体内均可增强人肝癌细胞系SMMC - 7721的放射敏感性。
Int J Radiat Biol. 2015 Feb;91(2):202-8. doi: 10.3109/09553002.2015.966209. Epub 2015 Jan 27.

引用本文的文献

1
Lupeol: ethnopharmacological insights and therapeutic potential in human health.羽扇豆醇:民族药理学见解及其对人类健康的治疗潜力。
3 Biotech. 2025 Jul;15(7):199. doi: 10.1007/s13205-025-04325-2. Epub 2025 May 30.
2
An updated review deciphering the anticancer potential of pentacyclic triterpene lupeol and its nanoformulations.一篇关于解读五环三萜羽扇豆醇及其纳米制剂抗癌潜力的最新综述。
Front Pharmacol. 2025 May 9;16:1594901. doi: 10.3389/fphar.2025.1594901. eCollection 2025.
3
Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications.
肝细胞癌的放射抗性:生物学基础与治疗意义
Int J Mol Sci. 2025 Feb 21;26(5):1839. doi: 10.3390/ijms26051839.
4
Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review.肝细胞癌放射敏感性机制研究进展:综述
Chin J Cancer Res. 2023 Jun 30;35(3):266-282. doi: 10.21147/j.issn.1000-9604.2023.03.06.
5
Drug-loaded PEG-PLGA nanoparticles for cancer treatment.用于癌症治疗的载药聚乙二醇-聚乳酸-羟基乙酸共聚物纳米颗粒
Front Pharmacol. 2022 Aug 19;13:990505. doi: 10.3389/fphar.2022.990505. eCollection 2022.